From Ars Technica
The DEA banned a drug some opioid users called a miracle

Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
TechStar AsiaIdeas without bordersAsia & global innovationFrom Ars Technica

Researchers say the Schedule I ban could kill studies of a promising opioid treatment.